GREGORY FROST v. PCRMC MEDICAL GROUP, INC., D/B/A PHELPS HEALTH MEDICAL GROUP

CourtMissouri Court of Appeals
DecidedJuly 10, 2024
DocketSD37969
StatusPublished

This text of GREGORY FROST v. PCRMC MEDICAL GROUP, INC., D/B/A PHELPS HEALTH MEDICAL GROUP (GREGORY FROST v. PCRMC MEDICAL GROUP, INC., D/B/A PHELPS HEALTH MEDICAL GROUP) is published on Counsel Stack Legal Research, covering Missouri Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
GREGORY FROST v. PCRMC MEDICAL GROUP, INC., D/B/A PHELPS HEALTH MEDICAL GROUP, (Mo. Ct. App. 2024).

Opinion

In Division

GREGORY FROST, ) ) Respondent, ) ) No. SD37969 vs. ) ) FILED: July 10, 2024 PCRMC MEDICAL GROUP, INC., ) D/B/A PHELPS HEALTH MEDICAL GROUP, ) ) Appellant. )

APPEAL FROM THE CIRCUIT COURT OF PHELPS COUNTY

Honorable William Earl Hickle, Judge

AFFIRMED IN PART, REVERSED IN PART AND REMANDED WITH DIRECTIONS

Gregory Frost (“Frost”) claimed he became addicted to opioids due to the negligence of

PCRMC Medical Group, Inc., d/b/a Phelps Health Medical Group (“Medical Group”). 1 A jury

found that Frost incurred compensatory damages in the amount of $200,000, that comparative

fault for said damages was ninety percent attributable to Frost and ten percent attributable to

Medical Group, and that Medical Group was liable for $500,000 in punitive damages. On

appeal, Medical Group raises six points asserting that Frost’s negligence claim was partially

1 This opinion will discuss opioid medications—including oxycodone and fentanyl—and dosages of such medications in detail. Because there is a range of opioid medications, each with varying properties and potencies, a uniform way to measure a dosage of any particular opioid is to compare its potency to milligrams of morphine, otherwise referred to as morphine milligram equivalents (“MME”) or morphine equivalent daily doses (“MED”). foreclosed by the statute of limitations (point 1), the negligence verdict director allowed for a

roving commission (point 2), the punitive damages verdict director was not supported by clear

and convincing evidence (point 3), the resulting punitive damages award violated due process

(point 4), and certain exhibits admitted into evidence were inadmissible hearsay (points 5 and 6).

We affirm in part, reverse in part, and remand with directions.

Factual and Procedural Background

Frost suffers from chronic pain syndrome resulting from trauma he sustained in a 2002

motorcycle accident. For eight-to-nine years, prior to any involvement by Medical Group in

Frost’s treatment, Frost received a low dose opioid medication regimen consisting of thirty-to-

forty-five MME of oxycodone per day to treat his pain.

In July of 2011, a Medical Group physician, Dr. Bohdan Lebedowicz provided Frost

emergency treatment, prescribing him a thirty-day supply of Endocet (a combination of

oxycodone and Tylenol), at a dosage of thirty MME, for his chronic pain. Dr. Lebedowicz also

referred Frost to a pain specialist, but Frost did not follow up with this referral until almost two

years later.

Dr. Lebedowicz, thereafter, began serving as Frost’s primary care physician and, over the

next couple of years, increased Frost’s opioid regimen several times. In February of 2012, Dr.

Lebedowicz increased Frost’s oxycodone dosage to 45 MME per day after Frost complained he

had injured his back. Then, in June of 2012, Frost complained that his pain was “much worse”

following a road trip to Florida, and Dr. Lebedowicz added Duragesic (a fentanyl patch) to the

regimen, resulting in a total opioid dosage of 105 MME per day. A sleep study that Dr.

Lebedowicz ordered around this time reflected that Frost had reported he had used illicit

narcotics, such as heroin or cocaine, in the past. Frost continued to complain of uncontrolled

2 shoulder, leg, and back pain, and, in response, Dr. Lebedowicz doubled the dosage of the

fentanyl patch in February of 2013 and again in April of 2013, resulting in a total opioid dosage

of 185 MME per day.

Frost’s opioid prescriptions remained unchanged for the next seventeen months. In May

of 2013, Frost followed up with the July 2011 referral by Dr. Lebedowicz to a pain specialist. In

the report following that consultation, a copy of which Dr. Lebedowicz received, the pain

specialist noted the following:

[Frost] will keep his pain medications with Dr. Lebedowicz as he is on high doses but these are not right for this . . . . [W]e would recommend decreasing his dose if possible. [H]e is currently cutting his fentanyl patches - - in half, for what reason, I am not really sure. The story seems to go round and round and I am unable to detect why he is cutting them in half. But, nonetheless, they need to be decreased if possible.

In addition to the pain specialist referral, Dr. Lebedowicz referred Frost to a neurosurgeon, a

sports medicine specialist, and an orthopedist. At an appointment with Dr. Lebedowicz in

September of 2013, the patient intake notes reflect that Frost “[t]ried to quit [the] [p]atch but was

unable to do without.” Dr. Lebedowicz intended to reduce Frost’s opioids in the event of a

successful pain reduction by other means. In September of 2014, Frost tried to reach Dr.

Lebedowicz by telephone and left messages stating that his prescribed opioids were not

controlling his pain, he suspected the medication was fake, he went to the emergency room but

was unable to secure narcotics, and he had to acquire some pills from his brother-in-law. Dr.

Lebedowicz met with Frost and increased his oxycodone dosage, thereby increasing Frost’s total

opioid dosage with the fentanyl patch to 300 MME per day. Dr. Lebedowicz also ordered a

urine screen to ensure compliance with the prescription regimen. The urine screen confirmed the

presence of the prescribed opioids but also revealed the presence of marijuana, which was illegal

at the time.

3 Dr. Lebedowicz withdrew as Frost’s primary care physician the following January of

2015, noting he felt very uncomfortable providing additional care after Frost admitted he was

using marijuana to treat his pain. Frost reported that he had ran out of his prescribed opioids, had

been experiencing uncontrollable crying spells, and was in extreme pain. Dr. Lebedowicz

observed that Frost “may be going through withdrawal.” Dr. Lebedowicz refilled Frost’s

medications and arranged for another Medical Group physician, Dr. Donald James to take over

Frost’s pain management needs going forward.

As his primary care physician, Dr. James had a total of four appointments with Frost

occurring between January 2015 and February 2016. During this period, Dr. James continued

Frost on the same opioid regimen Dr. Lebedowicz had established, amounting to approximately

300 MME per day. Dr. James warned that he would not serve as Frost’s physician if Frost

continued to smoke marijuana. In February 2016, Dr. James noted that Frost had continued his

opioid regimen and had “done well with no new complaints.” In May of 2016, Frost informed

Dr. James that he had quit consuming marijuana as instructed. Dr. James accepted a managerial

position in the summer of 2016 and ultimately transferred the care and treatment of Frost to

another Medical Group physician, Dr. Chadwell Vail.

Dr. Vail’s first visit with Frost occurred in July of 2016, at which time Frost discussed his

history of chronic pain and reported feeling “well controlled on [the] current medication

regimen.” Dr. Vail continued Frost on this regimen and, although Frost did not appear at his

next scheduled visit, Frost was able to continue receiving his scripts by going to Dr. Vail’s office

once a month and speaking to staff members to confirm the regimen was still effective and that

he was not experiencing any problems.

It was almost a year later, in June of 2017, when Dr. Vail next saw Frost in an

4 appointment setting. At that visit, Frost expressed a desire to be off of fentanyl completely and

claimed he was attempting to wean himself down from the prescribed dosage that had been in

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Peters v. General Motors Corp.
200 S.W.3d 1 (Missouri Court of Appeals, 2006)
Montgomery v. South County Radiologists, Inc.
49 S.W.3d 191 (Supreme Court of Missouri, 2001)
Coon v. Dryden
46 S.W.3d 81 (Missouri Court of Appeals, 2001)
St. Joseph's Hospital of Kirkwood v. Schierman
829 S.W.2d 4 (Missouri Court of Appeals, 1992)
Rinehart v. Shelter General Insurance Co.
261 S.W.3d 583 (Missouri Court of Appeals, 2008)
Sharp v. Robberson
495 S.W.2d 394 (Supreme Court of Missouri, 1973)
Twin Chimneys Homeowners Ass'n v. J.E. Jones Construction Co.
168 S.W.3d 488 (Missouri Court of Appeals, 2005)
Porter v. Director of Revenue
168 S.W.3d 147 (Missouri Court of Appeals, 2005)
Klotz v. St. Anthony's Medical Center
311 S.W.3d 752 (Supreme Court of Missouri, 2010)
Alcorn v. Union Pacific Railroad
50 S.W.3d 226 (Supreme Court of Missouri, 2001)
Gilliland v. Missouri Athletic Club
273 S.W.3d 516 (Supreme Court of Missouri, 2009)
Menaugh v. Resler Optometry, Inc.
799 S.W.2d 71 (Supreme Court of Missouri, 1990)
Weiss v. Rojanasathit
975 S.W.2d 113 (Supreme Court of Missouri, 1998)
Rodriguez v. Suzuki Motor Corp.
936 S.W.2d 104 (Supreme Court of Missouri, 1996)
Lashmet v. McQueary
954 S.W.2d 546 (Missouri Court of Appeals, 1997)
Citizens Bank of Appleton City v. Schapeler
869 S.W.2d 120 (Missouri Court of Appeals, 1993)
John Coomer v. Kansas City Royals Baseball Corporation
437 S.W.3d 184 (Supreme Court of Missouri, 2014)
Patrick Blanks v. Fluor Corporation
450 S.W.3d 308 (Missouri Court of Appeals, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
GREGORY FROST v. PCRMC MEDICAL GROUP, INC., D/B/A PHELPS HEALTH MEDICAL GROUP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gregory-frost-v-pcrmc-medical-group-inc-dba-phelps-health-medical-moctapp-2024.